Stealth BioTherapeutics was founded in 2007. The company specializes in creating novel therapeutic compounds aimed at treating mitochondrial dysfunction. Its mission centers on the discovery, development, and commercialization of advanced therapies for conditions linked to impaired mitochondrial function and other prevalent age-related diseases.

Do read about some of the most popular patents of Stealth BioTherapeutics which have been covered by us in this article and also you can find Stealth BioTherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Stealth BioTherapeutics patent portfolio.

How many patents does Stealth BioTherapeutics have?

Stealth BioTherapeutics has a total of 672 patents globally. These patents belong to 97 unique patent families. Out of 672 patents, 429 patents are active.

How Many Patents did Stealth BioTherapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Stealth BioTherapeutics patents are Alive/Dead?

Worldwide Patents

How Many Patents did Stealth BioTherapeutics File in Different Countries?

Countries in which Stealth BioTherapeutics Filed Patents

Where are Research Centers of Stealth BioTherapeutics Patents Located?

10 Best Stealth BioTherapeutics Patents

US20130303436A1 is the most popular patent in the Stealth BioTherapeutics portfolio. It has received 64 citations so far from companies like Nacuity Pharmaceuticals, Terenki International Limited.

Below is the list of 10 most cited patents of Stealth BioTherapeutics:

What Percentage of Stealth BioTherapeutics US Patent Applications were Granted?

Stealth BioTherapeutics (Excluding its subsidiaries) has filed 167 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 67 have been granted leading to a grant rate of 47.52%.

Below are the key stats of Stealth BioTherapeutics patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Stealth BioTherapeutics?

What are Stealth BioTherapeutics key innovation segments?

What Technologies are Covered by Stealth BioTherapeutics?

The chart below distributes patents filed by Stealth BioTherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Stealth BioTherapeutics thinks it’s important to protect particular technological inventions.

R&D Focus: How has Stealth BioTherapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Stealth BioTherapeutics?

The post Stealth BioTherapeutics Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

Lightcast Discovery founded in 2019, Lightcast is developing an advanced droplet-based platform that enables deeper insights into cellular function. Unlike traditional microfluidic systems, it allows precise control and tracking of droplets for diverse assays. This scalable and flexible technology accelerates research and optimizes workflows in drug discovery, therapeutics, and applied biologics.

Do read about some of the most popular patents of Lightcast Discovery which have been covered by us in this article and also you can find Lightcast Discovery patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Lightcast Discovery patent portfolio.

How many patents does Lightcast Discovery have?

Lightcast Discovery has a total of 296 patents globally. These patents belong to 37 unique patent families. Out of 296 patents, 230 patents are active.

How Many Patents did Lightcast Discovery File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Lightcast Discovery patents are Alive/Dead?

Worldwide Patents

How Many Patents did Lightcast Discovery File in Different Countries?

Countries in which Lightcast Discovery Filed Patents

Where are Research Centres of Lightcast Discovery Patents Located?

10 Best Lightcast Discovery Patents

WO2020104769A1 is the most popular patent in the Lightcast Discovery portfolio. It has received 13 citations so far from companies like Siemens Healthcare Diagnostics and Janssen Biotech Inc.

Below is the list of 10 most cited patents of Lightcast Discovery:

What Percentage of Lightcast Discovery US Patent Applications were Granted?

Lightcast Discovery (Excluding its subsidiaries) has filed 39 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 18 have been granted leading to a grant rate of 94.74%.

Below are the key stats of Lightcast Discovery patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Lightcast Discovery?

What are Lightcast Discovery key innovation segments?

What Technologies are Covered by Lightcast Discovery?

The chart below distributes patents filed by Lightcast Discovery in different countries on the basis of the technology protected in patents. It also represents the markets where Lightcast Discovery thinks it’s important to protect particular technological inventions.

R&D Focus: How has Lightcast Discovery search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Lightcast Discovery?

The post Lightcast Discovery Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

Regeneron Pharmaceuticals founded in 1988, is a biotechnology company dedicated to inventing, developing, and commercializing life-transforming medicines for serious diseases. With a growing global network, the company is redefining approaches to science, manufacturing, and commercialization, while shaping new ways to think about health and innovation.

Do read about some of the most popular patents of Regeneron which have been covered by us in this article and also you can find Regeneron patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Regeneron patent portfolio.

How many patents does Regeneron have?

Regeneron has a total of 23419 patents globally. These patents belong to 8443 unique patent families. Out of 23419 patents, 21287 patents are active.

How Many Patents did Regeneron File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Regeneron patents are Alive/Dead?

Worldwide Patents

How Many Patents did Regeneron File in Different Countries?

Countries in which Regeneron Filed Patents

10 Best Regeneron Patents

WO2015112800A1 is the most popular patent in the Regeneron portfolio. It has received 879 citations so far from companies like Asia Biotech Pte Ltd, Novartis and Anaptysbio.

Below is the list of 10 most cited patents of Regeneron:

What Percentage of Regeneron US Patent Applications were Granted?

Regeneron (Excluding its subsidiaries) has filed 2337 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1150 have been granted leading to a grant rate of 77.03%.

Below are the key stats of Regeneron patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Regeneron?

What are Regeneron key innovation segments?

What Technologies are Covered by Regeneron?

The chart below distributes patents filed by Regeneron in different countries on the basis of the technology protected in patents. It also represents the markets where Regeneron thinks it’s important to protect particular technological inventions.

R&D Focus: How has Regeneron search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Regeneron?

The post Regeneron Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

Treeline Biosciences, founded in 2021, is a biotechnology company developing precision medicines with a strong focus on cancer. The company integrates biology, chemistry, computation, structural biology, and protein science to address complex drug targets and advance breakthrough therapies.

Do read about some of the most popular patents of Treeline Biosciences which have been covered by us in this article and also you can find Treeline Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Treeline Biosciences patent portfolio.

How many patents does Treeline Biosciences have?

Treeline Biosciences has a total of 115 patents globally. These patents belong to 17 unique patent families. Out of 115 patents, 107 patents are active.

How Many Patents did Treeline Biosciences File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Treeline Biosciences patents are Alive/Dead?

Worldwide Patents

How Many Patents did Treeline Biosciences File in Different Countries?

Countries in which Treeline Biosciences Filed Patents

Where are Research Centers of Treeline Biosciences Patents Located?

Best Treeline Biosciences Patents

WO2024112654A1 is the most popular patent in the Treeline Biosciences portfolio. It has received 10 citations so far from companies like Quanta Therapeutics, Revolution Medicines,

What are Treeline Biosciences key innovation segments?

What Technologies are Covered by Treeline Biosciences ?

The chart below distributes patents filed by Treeline Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Treeline Biosciences thinks it’s important to protect particular technological inventions.

R&D Focus: How has Treeline Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Treeline Biosciences?

The post Treeline Biosciences Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

Pheon Therapeutics was founded in 2022. Pheon Therapeutics is developing next-generation ADCs to treat solid tumors and liquid cancers that are resistant to other treatments, using a tailored approach with novel and clinically validated monoclonal antibodies. Their lead program targets a novel biomarker expressed in a wide range of solid tumors and is expected to reach IND within 18 months. Backed by expert healthcare investors, Pheon has a strong leadership team and state-of-the-art labs in London and Boston.

Do read about some of the most popular patents of Pheon Therapeutics which have been covered by us in this article and also you can find Pheon Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pheon Therapeutics patent portfolio.

How many patents does Pheon Therapeutics have?

Pheon Therapeutics has a total of 52 patents globally. These patents belong to 12 unique patent families. Out of 52 patents, 39 patents are active.

How Many Patents did Pheon Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Pheon Therapeutics patents are Alive/Dead?

Worldwide Patents

How Many Patents did Pheon Therapeutics File in Different Countries?

Countries in which Pheon Therapeutics Filed Patents

Where are Research Centers of Pheon Therapeutics Patents Located?

Best Pheon Therapeutics Patents

US20210371413A1 is the most popular patent in the Pheon Therapeutics portfolio. It has received 26 citations so far from company like Augmedics.

What are Pheon Therapeutics key innovation segments?

What Technologies are Covered by Pheon Therapeutics?

The chart below distributes patents filed by Pheon Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Pheon Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Pheon Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Pheon Therapeutics?

The post Pheon Therapeutics Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

ENSEM Therapeutics was founded in 2021. ENSEM is an innovative drug discovery and development company that utilizes its proprietary Kinetic Ensemble platform to create cutting-edge small molecule precision medicines for oncology, with plans for potential expansion into genetic disorders and other therapeutic areas.

Do read about some of the most popular patents of ENSEM Therapeutics which have been covered by us in this article and also you can find ENSEM Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ENSEM Therapeutics patent portfolio.

How many patents does ENSEM Therapeutics have?

ENSEM Therapeutics has a total of 58 patents globally. These patents belong to 15 unique patent families. Out of 58 patents, 53 patents are active.

How Many Patents did ENSEM Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many ENSEM Therapeutics patents are Alive/Dead?

Worldwide Patents

How Many Patents did ENSEM Therapeutics File in Different Countries?

Countries in which ENSEM Therapeutics Filed Patents

Where are Research Centers of ENSEM Therapeutics Patents Located?

Best ENSEM Therapeutics Patents

WO2023244713A1 is the most popular patent in the ENSEM Therapeutics portfolio. It has received 6 citations so far from companies like Revolution Medicines.

What Percentage of ENSEM Therapeutics US Patent Applications were Granted?

ENSEM Therapeutics (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 has been granted leading to a grant rate of 0%.

Below are the key stats of ENSEM Therapeutics patent prosecution at the USPTO.

Which Law Firms are Managing US Patents for ENSEM Therapeutics?

What are ENSEM Therapeutics key innovation segments?

What Technologies are Covered by ENSEM Therapeutics?

The chart below distributes patents filed by ENSEM Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where ENSEM Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has ENSEM Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by ENSEM Therapeutics?

The post ENSEM Therapeutics Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

Renew Biopharma was founded in 2017. Renew Biopharma is a San Diego based biotech startup developing novel therapeutic molecules through synthetic biology and enzyme engineering. The company focuses on treatments for neuroinflammation, chronic pain, traumatic brain injury, and neurodegenerative diseases. Its proprietary technologies enable the design of innovative compounds that can effectively cross the blood–brain barrier.

Do read about some of the most popular patents of Renew Biopharma which have been covered by us in this article and also you can find Renew Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Renew Biopharma patent portfolio.

How many patents does Renew Biopharma have?

Renew Biopharma has a total of 53 patents globally. These patents belong to 24 unique patent families. Out of 53 patents, 9 patents are active.

How Many Patents did Renew Biopharma File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Renew Biopharma patents are Alive/Dead?

Worldwide Patents

How Many Patents did Renew Biopharma File in Different Countries?

Countries in which Renew Biopharma Filed Patents

 Where are Research Centers of Renew Biopharma Patents Located?

The Research Centre for all the Renew Biopharma patents is the United States of America.

Best Renew Biopharma Patents

WO2019183152A1 is the most popular patent in the Renew Biopharma portfolio. It has received 23 citations so far from companies like Ginkgo Bioworks, Invizyne Technologies etc.

Below is the list of most cited patents of Renew Biopharma:

 What Percentage of Renew Biopharma US Patent Applications were Granted?

Renew Biopharma (Excluding its subsidiaries) has filed 29 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 19 has been granted leading to a grant rate of 70%.

Below are the key stats of Renew Biopharma patent prosecution at the USPTO.

Which Law Firms are Managing US Patents for Renew Biopharma?

What are Renew Biopharma key innovation segments?

What Technologies are Covered by Renew Biopharma?

The chart below distributes patents filed by Renew Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Renew Biopharma thinks it’s important to protect particular technological inventions.

R&D Focus: How has Renew Biopharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Renew Biopharma?

The post Renew Biopharma Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

Eikon Therapeutics founded in 2019, Eikon Therapeutics is a biopharmaceutical company developing novel treatments for life-threatening diseases through breakthrough technology at the intersection of biology, engineering, and chemistry. Its discovery platform, based on Nobel Prize-winning innovations, uses advanced microscopes to track protein movement in living cells. By enabling real-time, molecular-level insights, Eikon unlocks previously inaccessible drug targets and accelerates the discovery of life-saving therapies.

Do read about some of the most popular patents of Eikon Therapeutics which have been covered by us in this article and also you can find Eikon Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Eikon Therapeutics patent portfolio.

How many patents does Eikon Therapeutics have?

Eikon Therapeutics has a total of 33 patents globally. These patents belong to 18 unique patent families. Out of 33 patents, 19 patents are active.

How Many Patents did Eikon Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Eikon Therapeutics patents are Alive/Dead?

Worldwide Patents

How Many Patents did Eikon Therapeutics File in Different Countries?

Countries in which Eikon Therapeutics Filed Patents

Where are Research Centres of Eikon Therapeutics Patents Located?

The Research Centre for all the Eikon Therapeutics patents is the United States of America.

Eikon Therapeutics Best Patent

US9062026B2 is the most popular patent in the Eikon Therapeutics portfolio. It has received 6 citations so far from companies like Cleave Biosciences and Turbine Simulated Cell Technologies Ltd.

What Percentage of Eikon Therapeutics US Patent Applications were Granted?

Eikon Therapeutics (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Eikon Therapeutics patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Eikon Therapeutics?

List of Eikon Therapeutics Patents

What are Eikon Therapeutics key innovation segments?

What Technologies are Covered by Eikon Therapeutics?

The chart below distributes patents filed by Eikon Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Eikon Therapeutics thinks it’s important to protect particular technological inventions.

R&D Focus: How has Eikon Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Eikon Therapeutics?

The post Eikon Therapeutics Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

Enveda Therapeutics founded in 2019, Enveda is a biotechnology company leveraging nature’s chemical diversity to accelerate drug discovery. Using advanced computational tools, it identifies and characterizes previously unexplored molecules from living organisms, building a vast library of chemical biodiversity. This approach enables the development of novel medicines to address critical healthcare challenges.

Do read about some of the most popular patents of Enveda Therapeutics which have been covered by us in this article and also you can find Enveda Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Enveda Therapeutics patent portfolio.

How many patents does Enveda Therapeutics have?

Enveda Therapeutics has a total of 21 patents globally. These patents belong to 9 unique patent families. Out of 21 patents, 13 patents are active.

How Many Patents did Enveda Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Enveda Therapeutics patents are Alive/Dead?

Worldwide Patents

How Many Patents did Enveda Therapeutics File in Different Countries?

Countries in which Enveda Therapeutics Filed Patents

Where are Research Centres of Enveda Therapeutics Patents Located?

Enveda Therapeutics Best Patent

US20250189496A1 is the most popular patent in the Enveda Therapeutics portfolio. It has received 1 citations so far from company like Microsoft.

List of Enveda Therapeutics Patents

What are Enveda Therapeutics key innovation segments?

What Technologies are Covered by Enveda Therapeutics?

The chart below distributes patents filed by Enveda Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Enveda Therapeutics thinks it’s important to protect particular technological inventions.

R&D Focus: How has Enveda Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Enveda Therapeutics?

The post Enveda Therapeutics Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.

Vitaeris founded in 2016, Vitaeris is a biotechnology company focused on advancing treatments for chronic inflammatory diseases. The company holds exclusive global rights to Clazakizumab, a best-in-class anti-interleukin-6 monoclonal antibody, licensed from Alder Biopharmaceuticals. Vitaeris is dedicated to developing innovative therapeutic applications across healthcare and pharmaceutical domains.

Do read about some of the most popular patents of Vitaeris which have been covered by us in this article and also you can find Vitaeris patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vitaeris patent portfolio.

How many patents does Vitaeris have?

Vitaeris has a total of 140 patents globally. These patents belong to 7 unique patent families. Out of 140 patents, 81 patents are active.

How Many Patents did Vitaeris File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Vitaeris patents are Alive/Dead?

Worldwide Patents

How Many Patents did Vitaeris File in Different Countries?

Countries in which Vitaeris Filed Patents

Where are Research Centres of Vitaeris Patents Located?

10 Best Vitaeris Patents

US7935340B2 is the most popular patent in the Vitaeris portfolio. It has received 194 citations so far from companies like Alder Biopharmaceuticals, Kite Pharma and H Lundbeck As.

Below is the list of 10 most cited patents of Vitaeris:

What Percentage of Vitaeris US Patent Applications were Granted?

Vitaeris (Excluding its subsidiaries) has filed 74 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 57 have been granted leading to a grant rate of 79.17%.

Below are the key stats of Vitaeris patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Vitaeris?

What are Vitaeris key innovation segments?

What Technologies are Covered by Vitaeris?

The chart below distributes patents filed by Vitaeris in different countries on the basis of the technology protected in patents. It also represents the markets where Vitaeris thinks it’s important to protect particular technological inventions.

R&D Focus: How has Vitaeris search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Vitaeris?

The post Vitaeris Patents – Insights & Stats (Updated 2025) appeared first on Insights;Gate.